Kennedy Grace Em, Craig Julie, McMahon Samuel E, Cusick Laurence A
Department of Trauma & Orthopaedics, Royal Victoria Hospital, 274 Grosvenor Road, Belfast, N. Ireland, BT12 6BA.
Department of Trauma & Orthopaedics, Royal Cornwall Hospital Treliske, Truro, Cornwall, TR1 3LJ (Present address).
Ulster Med J. 2024 Dec;93(2):48-54. Epub 2024 Dec 11.
Total hip arthroplasty (THA) for displaced intracapsular hip fracture is increasingly common. The aim of this project was to determine all-cause mortality rates, rates of significant complications and functional outcomes following THA for fractures.
An inpatient database search identified all patients undergoing THA for displaced intracapsular fracture in Northern Ireland's regional trauma centre from 2010-2017. Regional electronic healthcare systems were reviewed for evidence of complications.
After exclusions, 345 cases were identified. The median age was 70 years (31 - 91 years).Median follow-up was 4.3 years (1.6 - 9.3 years). The all-cause mortality rate was 0.3% at 30 days, 3.2% at one year, and 5.5% at two years.Seven patients (2.0%) experienced dislocations. Most occurred within 60 days; five patients underwent revision.Radiographic evidence of heterotopic ossification (HO) was seen in 48 patients (13.8%).Re-operation was required for 16 patients (4.6%). This included 5 dislocations, eight cases of periprosthetic fractures (in seven patients), two cases of infection, and one case of symptomatic HO.Pre-injury, 96.2% (332/345) were independently mobile, and after one year 78.9% (262/332) of those patients remained so. Pre-injury, 96.2% obtained the maximum functional score (Barthel Index, maximum score of 20), and after one year 78.9% (262/332) of these continued to report a maximum Barthel Index score.
THA for hip fracture holds a 2.0% risk of dislocation and a 4.6% risk of re-operation. HO is common but seldom requires re-operation. All-cause mortality rates and functional levels compared favourably with current literature.
全髋关节置换术(THA)用于治疗移位性囊内髋关节骨折越来越普遍。本项目的目的是确定THA治疗骨折后的全因死亡率、严重并发症发生率和功能结局。
通过对住院患者数据库进行检索,确定了2010年至2017年在北爱尔兰地区创伤中心接受THA治疗移位性囊内骨折的所有患者。查阅区域电子医疗系统以获取并发症证据。
排除后,共确定345例病例。中位年龄为70岁(31 - 91岁)。中位随访时间为4.3年(1.6 - 9.3年)。30天全因死亡率为0.3%,1年时为3.2%,2年时为5.5%。7例患者(2.0%)发生脱位。大多数脱位发生在60天内;5例患者接受了翻修手术。48例患者(13.8%)有异位骨化(HO)的影像学证据。16例患者(4.6%)需要再次手术。这包括5例脱位、8例假体周围骨折(7例患者)、2例感染和1例有症状的HO。受伤前,96.2%(332/345)患者可独立活动,1年后这些患者中有78.9%(262/332)仍保持独立活动。受伤前,96.2%的患者获得最大功能评分(巴氏指数,满分20分),1年后这些患者中有78.9%(262/332)继续报告巴氏指数最高评分。
髋关节骨折行THA有2.0%的脱位风险和4.6%的再次手术风险。HO很常见,但很少需要再次手术。全因死亡率和功能水平与当前文献相比具有优势。